D.E. Shaw & Co’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,428
Closed -$306K 4816
2025
Q4
$306K Buy
+37,428
New +$277K ﹤0.01% 4139
2023
Q1
Sell
-47,971
Closed -$311K 4680
2022
Q4
$311K Buy
47,971
+1,568
+3% +$12.9K ﹤0.01% 4072
2022
Q3
$413K Sell
46,403
-4,065
-8% -$41.3K ﹤0.01% 4151
2022
Q2
$503K Sell
50,468
-14,342
-22% -$142K ﹤0.01% 4082
2022
Q1
$750K Buy
64,810
+10,219
+19% +$114K ﹤0.01% 4128
2021
Q4
$606K Buy
54,591
+767
+1% +$7.44K ﹤0.01% 4289
2021
Q3
$496K Sell
53,824
-47,508
-47% -$517K ﹤0.01% 4087
2021
Q2
$1.14M Buy
101,332
+60,011
+145% +$692K ﹤0.01% 3431
2021
Q1
$438K Sell
41,321
-2,962
-7% -$33.3K ﹤0.01% 3566
2020
Q4
$480K Buy
44,283
+28,432
+179% +$294K ﹤0.01% 3410
2020
Q3
$154K Sell
15,851
-1,234
-7% -$11.8K ﹤0.01% 3645
2020
Q2
$136K Sell
17,085
-6,522
-28% -$67.3K ﹤0.01% 3854
2020
Q1
$205K Sell
23,607
-46,833
-66% -$487K ﹤0.01% 3637
2019
Q4
$797K Buy
70,440
+37,748
+115% +$402K ﹤0.01% 3132
2019
Q3
$355K Buy
+32,692
New +$356K ﹤0.01% 3370
2019
Q2
Sell
-23,068
Closed -$283K 3763
2019
Q1
$283K Buy
23,068
+12,648
+121% +$154K ﹤0.01% 3245
2018
Q4
$123K Sell
10,420
-11,689
-53% -$161K ﹤0.01% 3617
2018
Q3
$318K Buy
22,109
+8,037
+57% +$111K ﹤0.01% 3334
2018
Q2
$210K Buy
+14,072
New +$196K ﹤0.01% 3540
2018
Q1
Sell
-17,580
Closed -$222K 3644
2017
Q4
$222K Buy
17,580
+574
+3% +$7.25K ﹤0.01% 3387
2017
Q3
$220K Buy
+17,006
New +$224K ﹤0.01% 3275
2017
Q2
Sell
-11,202
Closed -$134K 3464
2017
Q1
$134K Sell
11,202
-16,558
-60% -$210K ﹤0.01% 3173
2016
Q4
$383K Buy
27,760
+11,371
+69% +$158K ﹤0.01% 3000
2016
Q3
$220K Buy
+16,389
New +$199K ﹤0.01% 3169
2016
Q1
Sell
-26,672
Closed -$316K 3624
2015
Q4
$316K Sell
26,672
-239
-0.9% -$2.94K ﹤0.01% 3340
2015
Q3
$314K Buy
+26,911
New +$357K ﹤0.01% 3328

Other funds holding LFCR